<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Syroegin EA</submitter><funding>NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>152-161</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9071271</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>29(2)</volume><pubmed_abstract>Ribosome-targeting antibiotics serve as powerful antimicrobials and as tools for studying the ribosome, the catalytic peptidyl transferase center (PTC) of which is targeted by many drugs. The classic PTC-acting antibiotic chloramphenicol (CHL) and the newest clinically significant linezolid (LZD) were considered indiscriminate inhibitors of protein synthesis that cause ribosome stalling at every codon of every gene being translated. However, recent discoveries have shown that CHL and LZD preferentially arrest translation when the ribosome needs to polymerize particular amino acid sequences. The molecular mechanisms that underlie the context-specific action of ribosome inhibitors are unknown. Here we present high-resolution structures of ribosomal complexes, with or without CHL, carrying sp</pubmed_abstract><journal>Nature structural &amp; molecular biology</journal><pubmed_title>Structural basis for the context-specific action of the classic peptidyl transferase inhibitor chloramphenicol.</pubmed_title><pmcid>PMC9071271</pmcid><funding_grant_id>R01 GM132302</funding_grant_id><funding_grant_id>P30 GM124165</funding_grant_id><funding_grant_id>S10 OD021527</funding_grant_id><pubmed_authors>Micura R</pubmed_authors><pubmed_authors>Flemmich L</pubmed_authors><pubmed_authors>Vazquez-Laslop N</pubmed_authors><pubmed_authors>Syroegin EA</pubmed_authors><pubmed_authors>Polikanov YS</pubmed_authors><pubmed_authors>Klepacki D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Structural basis for the context-specific action of the classic peptidyl transferase inhibitor chloramphenicol.</name><description>Ribosome-targeting antibiotics serve as powerful antimicrobials and as tools for studying the ribosome, the catalytic peptidyl transferase center (PTC) of which is targeted by many drugs. The classic PTC-acting antibiotic chloramphenicol (CHL) and the newest clinically significant linezolid (LZD) were considered indiscriminate inhibitors of protein synthesis that cause ribosome stalling at every codon of every gene being translated. However, recent discoveries have shown that CHL and LZD preferentially arrest translation when the ribosome needs to polymerize particular amino acid sequences. The molecular mechanisms that underlie the context-specific action of ribosome inhibitors are unknown. Here we present high-resolution structures of ribosomal complexes, with or without CHL, carrying sp</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Feb</publication><modification>2025-04-04T08:01:38.928Z</modification><creation>2025-04-04T08:01:38.928Z</creation></dates><accession>S-EPMC9071271</accession><cross_references><pubmed>35165455</pubmed><doi>10.1038/s41594-022-00720-y</doi></cross_references></HashMap>